Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Endo Health Solutions Inc    ENDP   US29264F2056

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

05/09/2012 | 02:44pm US/Eastern

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
React to this article
Latest news on ENDO HEALTH SOLUTIONS INC
03/02 Wall St. rallies; Nasdaq hits highest level since 2000
03/02 ENDO : Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for B..
02/23 ENDO : American Medical Systems Announces 1,000th Patient Enrolled in PROPPER Re..
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- 2nd Update
02/22DJValeant Pharmaceuticals to Buy Salix for About $10 Billion -- Update
02/20 Drugmaker Valeant close to buying Salix - source
02/13 EXCLUSIVE : Drugmaker Endo vying for Salix takeover
02/04 EXCLUSIVE - CINVEN TESTS APPETITE FO : sources
01/21DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
2014 U.S. court denies Ranbaxy's bid to block launch of rival generics
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF